News Overview

New residents at our Main Campus

Julijana Stula
Our newest residents are slowly getting ready to finally move into our new Switzerland Innovation Park Basel Area Site opening in 2022, in close collaboration with our partner SENN Development. Find out more about them, and why they choose to move into our Main Campus.

T3 Pharmaceuticals

T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviors of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads into the cells.

Basilea Pharmaceutical AG

Basilea Pharamceutica AG is a commercial stage biopharmaceutical company, focused on the development of products that address the medical challenges in the therapeutic areas of oncology and anti-infectives.

HORTUS – The eco-friendly office space
Exciting things are happening next door to our Main Camps in Allschwil. SENN Development, Herzog & de Meuron, and ZPF Engineers are jointly developing an office building with approx. 10,000 m2 of usable space for environmentally conscious (tech) companies. The building sets a new standard for sustainability: It pays back the grey building energy and is already energy-positive after about 30 years. Learn more here.

You may also like

The definite guide to getting new customers for your header image

The definite guide to finding new customers for your startup without spending money.

Finding new customers and creating a stable demand is at the top of every entrepreneur’s to-do…> Read more

Location matters

In the canton of Jura, innovation starts with time: The expertise in watchmaking was transferred into…> Read more
SIP Terasse

Open Day auf dem BaseLink Areal in Allschwil

In Allschwil bei Basel entsteht ein neuer Kristallisationspunkt für Life Science mit internationaler Ausstrahlung. Am Samstag,…> Read more

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.